BOSTON -- Carvedilol (Coreg, Coreg CR) helped to mitigate cardiac risk in patients undergoing pheochromocytoma surgery, researchers reported here. In a comparison of several blood pressure (BP) ...

November 17, 2006 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to advise on the use of carvedilol tablets in diabetic patients; the risk for potentially fatal ...

Philadelphia, PA - GlaxoSmithKline announced that the FDA has approved carvedilol (Coreg®) for patients who have had an MI and who have left ventricular dysfunction. Carvedilol is the only ...

Mar. 23 -- WEDNESDAY, Sept. 5 (HealthDay News) -- The U.S. Food and Drug Administration has approved the first generic versions of Coreg (carvedilol), used to treat high blood pressure, chronic heart ...

The first generic versions of GlaxoSmithKline’s cardiovascular agent Coreg – all 14 of them – have been approved by US regulators. The first generic versions of GlaxoSmithKline’s cardiovascular agent ...

A large head-to-head comparison of two widely used heart drugs known as beta blockers found one significantly superior in prolonging the lives of people with chronic heart failure. Some experts, ...

A report details "deviations" during manufacturing of more than 135,000 packages, which could possibly contribute to other ...

TRENTON, N.J. Teva has sued Apotex to prevent it from selling a generic version of the heart medication Coreg, according to Bloomberg. The two companies, as well as other generic drug makers, received ...

TORONTO--(BUSINESS WIRE)--Feb. 26, 2004--Biovail Corporation (NYSE:BVF)(TSX:BVF) announced today it has acquired the rights to a novel formulation of eprosartan (Teveten(R)) and a formulation for an ...

“This narrow, case-specific review of substantial evidence does not upset the careful balance struck by the Hatch-Waxman Act regarding section viii carve-outs.”- CAFC The U.S. Court of Appeals for the ...